Immunophotonics Secures $10 Million in Latest Series C Funding Round

Immunophotonics secured $10 million in its latest Series C, adding another data point to the FinTech funding market.

Immunophotonics Raises $10 million in Funding

Immunophotonics Secures Initial $10 Million Series C Financing and Appoints Robert H.

Investors Behind the Funding

The round was backed by Amsterdam UMC highlighting the potential of local tumor destruction. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Immunophotonics operates in FinTech. Immunophotonics's financing adds to recent private-market activity.

Strategic Use of Funds

lead this incredible team

Looking Ahead

Immunophotonics Secures Initial $10 Million Series C Financing and Appoints Robert H. Arch, Ph.D., as President and CEO

Source reference: original announcement/article.